Chairman & CEO
Bristol Myers Squibb
United States of America
Dr. Giovanni Caforio, M.D. serves as the Chief Executive Officer at Bristol-Myers Squibb Belgium NV/SA. Dr. Caforio has been the Chief Executive Officer of Bristol-Myers Squibb Farmacêutica Portuguesa, SA since May 05, 2015 and serves as its Director. Dr. Caforio serves as the Chief Executive Officer of Bristol-Myers Squibb Australia Pty Ltd. Dr. Caforio serves as Chief Operating Officer at Medarex, Inc. He has responsibility for leading a fully integrated worldwide commercial organization and Medarex-wide functions of Enterprise Services and Global Manufacturing & Supply. He has been the Chief Executive Officer of Bristol-Myers Squibb Company since May 05, 2015 and its Chairman since May 02, 2017. He served as Chief Operating Officer of Bristol-Myers Squibb Company from June 09, 2014 to May 05, 2015 and also served as its Chief Commercial Officer and Executive Vice President from November 13, 2013 to 2014. Dr. Caforio leads the Bristol-Myers Squibb Company's pharmaceutical business in the U.S. He served as Chief Commercial Officer at Medarex, Inc. Dr. Caforio served as the President of U.S. Pharmaceuticals at Bristol-Myers Squibb Company from October 2011 to November 2013. He served as Senior Vice President of U.S. Oncology, Worldwide Pharmaceuticals at Bristol-Myers Squibb Company from January 2007 to March 2009. He served as Senior Vice President of Global and U S Oncology at Bristol-Myers Squibb Company until October 2011 He served as Senior Vice President of Global Commercialization, Oncology and Immunology at Bristol-Myers Squibb from January 2011 to October 2011 and its Senior Vice President of Oncology, U.S. and Global Commercialization from March 2009 to May 2010, where he helped re-establish Bristol-Myers Squibb as a leader in Oncology, including the launch of YERVOY™, the Bristol-Myers Squibb's innovative immuno-oncology medicine for metastatic melanoma. As a leader, his focus is on developing talented leaders with the diverse experiences and competencies needed for the continued success of the Bristol-Myers Squibb Company. He joined Bristol-Myers Squibb in 2000 as Vice President and General Manager of Italy, in the Worldwide Medicines Group. In 2001, he assumed added responsibility for Greece and Israel and then all of South East Europe in 2003. From May 2004 to January 2007, he served as Senior Vice President of European Marketing and Brand Commercialization of Bristol-Myers Squibb. Since 2007, he served as Senior Vice President of U.S. Oncology of Bristol-Myers Squibb. Prior to joining Bristol-Myers Squibb, he spent 12 years with Abbott Laboratories in a number of leadership positions. He has been a Director of Bristol-Myers Squibb Company since June 09, 2014. He served as a Director of Capital Health System, Inc. until June 17, 2016.
Dr. Caforio is a member of the Board of Trustees of the Pharmaceutical Research and Manufacturers of America (PhRMA). He serves as a Member of Executive Committee at National Pharmaceutical Council. Dr. Caforio holds an M.D. from the University of Rome.